Back to Results
First PageMeta Content
Treatment of bipolar disorder / Mood disorders / Bipolar spectrum / Abnormal psychology / Neurotechnology / Major depressive disorder / Management of depression / Antidepressant / Electroconvulsive therapy / Psychiatry / Mental health / Medicine


ORIGINAL ARTICLE Prevention of Relapse Following Cognitive Therapy vs Medications in Moderate to Severe Depression Steven D. Hollon, PhD; Robert J. DeRubeis, PhD; Richard C. Shelton, MD; Jay D. Amsterdam, MD; Ronald M.
Add to Reading List

Open Document

File Size: 132,12 KB

Share Result on Facebook

City

Middlesex / Philadelphia / Tynya Patton / Washington / DC / Pilkonis / Nashville / London / /

Company

Placebo Group (n = 35) Adhere cADM Group / cADM Group (n = 34) Prior CT Group / GlaxoSmithKline / Prior CT Group (n = 35) Placebo Group / GE / John Wiley & Sons Inc / Cox / cP-P / Prior CT Group (n = 20) Prior ADM Group / American Psychiatric Press / /

Country

United Kingdom / /

Currency

USD / /

/

Event

Product Issues / Product Recall / Person Communication and Meetings / /

Facility

National Institute of Mental Health / Arch Gen Psychiatry / West Chester University / Vanderbilt University / New York State Psychiatric Institute / Wilson Hall / National Institute of Mental Health Treatment / ARCH GEN PSYCHIATRY/ VOL / University of Pennsylvania / /

IndustryTerm

pCT / depression treatment / prevention of depression / Treatment of Depression / treatment for depression / therapy for depression / treatment of patients with major depressive disorder / /

MedicalCondition

illness / posttraumatic stress disorder / chronic depression / transient withdrawal symptoms / clinically significant medical disorder / double depression / depression / especially paranoid personality disorder / II disorder / major depressive disorder / cognitive symptoms / full major depressive disorder / schizotypal personality disorder / personality disorders / I disorder / severe unipolar depression / severe depression / DSM-III-R Personality Disorders / /

MedicalTreatment

cognitive therapy / placebos / pharmacotherapy / psychotherapy / drug therapy / /

NaturalFeature

Shea MT / /

Organization

Department of Psychology / American Psychiatric Association / Amsterdam JD / University of Pennsylvania / Philadelphia / Psychiatric Institute / National Institute of Mental Health / Institute of Mental Health Treatment of Depression Collaborative Research Program / the University of Pennsylvania / West Chester University / Vanderbilt University / American Medical Association / Department of Mathematics and Applied Statistics / /

Person

Nathaniel R. Herr / Frances Shusman / Jay D. Amsterdam / Madeline M. Gladis / Andrew J. Tomarken / Edward Schweizer / Paula R. Young / Aaron T. Beck / Steven D. Hollon / Martin Szuba / Christine Johnson / Jessica LondaJacobs / Margaret L. Lovett / Cara C. Grugan / Sandra Seidel / Leslie Sokol / Miriam Hundert / Ronald M. Salomon / Ellen D. Stoddard / Robert J. DeRubeis / David Appelbaum / Robert Gallop / Judith Beck / Kelly Bemis Vitousek / Pamela FawcettPressman / Brent B. Freeman / Richard C. Shelton / Cory P. Newman / Julie L. Pickholtz / Nana A. Landenberger / Sabine Schmid / Mary Hooper / Joyce Bell / Laurel L. Brown / Karl N. Jannasch / Veni Linos / Barrie Franklin / Kirsten L. Haman / Michael Suminski / Richard C. Carson / Dorothy Tucker / Jan Fawcett / /

/

Position

blind clinical evaluator / Author / Dolan RT / Parloff MB / Bishop / treating psychiatrist / same psychiatrist / Fisher / /

Product

placebo / fluoxetine / Patients / 14 cADM group patients / Prozac / desipramine hydrochloride / 6 patients / medication / active medication / /

ProvinceOrState

New York / Connecticut / Maryland / Tennessee / Manitoba / Pennsylvania / Massachusetts / /

RadioStation

Quitkin FM / /

Technology

research protocol / /

URL

http /

SocialTag